Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999405 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
CDODA-Me has antineoplastic activity in bladder cancer cells by inducing ROS, which down-regulate Sp and Sp-regulated proteins. Thus, CDODA-Me has therapeutic potential in bladder cancer, and additional studies of the agent's efficacy and mode of action are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hisashi M.D., Ph.D., Rikiya M.D., Ph.D., Chinedu O. M.D., Goodwin G. Ph.D., Stephen Ph.D., Ashish M. M.D.,